Compare NRXP & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRXP | RMTI |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 35.1M |
| IPO Year | N/A | 1998 |
| Metric | NRXP | RMTI |
|---|---|---|
| Price | $2.10 | $0.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $30.50 | $2.50 |
| AVG Volume (30 Days) | ★ 455.8K | 237.5K |
| Earning Date | 11-17-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $242,000.00 | ★ $75,577,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $643.59 | $8.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.15 | $0.78 |
| 52 Week High | $6.01 | $2.41 |
| Indicator | NRXP | RMTI |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 44.45 |
| Support Level | $2.22 | $0.87 |
| Resistance Level | $2.39 | $0.97 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 3.41 | 40.02 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.